Nature Biotechnology
- 24, 1224 - 1226 (2006)
doi:10.1038/nbt1006-1224
Complementary therapies for inflammationYi Wang
Yi Wang is at Alexion Pharmaceuticals, Inc., 352 Knotter Drive, Cheshire, Connecticut 06410, USA wangy@alxn.com
Monoclonal antibodies against the human C5a receptor offer new therapeutic prospects for complement inhibition.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
